Abiologics
PrivateLast Round
VC Round
Jul 23, 2024
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Abiologics is a biotechnology company that develops a platform for designing and synthesizing supranatural biologics, known as Synteins, using generative artificial intelligence and non-standard amino acids.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abiologics Comparables
Compare Abiologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nabla Bio | 89% | |
| Accipiter Biosciences | 86% | |
| AI Proteins | 86% |
Abiologics Funding Rounds
Historical fundraising activity
Abiologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flagship Pioneering | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 12, 46% of headcount.
- Oct 12, 2026
Open roles increased to 8, doubling the trailing average.
Recent news
Latest coverage and updates
- hiresOct 20, 2026
Abiologics hires Per Greisen to lead its AI and machine learning strategy for de novo Synteins™ generation and the development of new biologics.
- hiresOct 20, 2026
Abiologics appoints Per Jr. Greisen as Chief Artificial Intelligence Officer in Massachusetts on Oct 20th '26; he leads the company's AI and machine learning strategy for its synthetic D-protein therapeutics platform.
Abiologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Abiologics's valuation, stock price, and market status.
Is Abiologics a public or private company?
Abiologics is a private company.
What is the current stock price of Abiologics?
Abiologics is a private company, so its shares have no public market price. Caplight tracks Abiologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abiologics worth (valuation)?
Valuation information for Abiologics is not publicly available.
Can I buy Abiologics stock?
Abiologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abiologics's last funding round?
Abiologics's most recent funding round was VC Round on July 23, 2024.
Who are the main investors in Abiologics?
Key investors in Abiologics include Flagship Pioneering.
Will Abiologics IPO soon?
No public IPO plans have been announced for Abiologics.
How can I track Abiologics secondary market activity?
Caplight tracks bids, offers, and trades in Abiologics's shares on secondary markets.